[1]
Anantharaman, K. 2008. Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. Kerala Medical Journal. 1, 1 (Sep. 2008), 33-34. DOI:https://doi.org/10.52314/kmj.2008.v1i1.98.